Five Prime Therapeutics (FPRX) Will Look into Glaxo Matter Following Notifications of Arrests
Tweet Send to a Friend
Five Prime Therapeutics (NASDAQ: FPRX) disclosed the following on Wednesday:On January 19, 2016, GlaxoSmithKline (“GSK”) informed Five Prime Therapeutics, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE